[Short-term perioperative antibacterial prophylaxis using imipenem-cilastatin versus acylureide penicillins in pacemaker implantation. A 30-month follow-up].
The authors have evaluated the efficacy of short term treatment with an imipenem-cilastatin combination in a selected group of 72 patients undergoing implant or substitution of a pacemaker and with associated pathology potentially increasing the risk of infection. After 30 months' follow-up, the authors underline the efficacy and advantages of this treatment.
Veneziani
N
N
Istituto di Cardiochirurgia, Università degli Studi di Bari.
De Pasquale
C
C
Baglietto
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D015377:Cilastatin / Q000008:administration & dosage* / Q000009:adverse effects; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D010406:Penicillins / Q000627:therapeutic use*; D011184:Postoperative Period; D011292:Premedication; D013997:Time Factors
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D010406:Penicillins; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination
Short-term profilassi antibatterica perioperatoria con imipenem-cilastatina versus acilureido-penicilline negli impianti di pace-makers. Follow-up a 30 mesi.